ADPT logo

Adaptive Biotechnologies (ADPT) Depreciation and amortization

annual D&A:

$19.26M-$2.98M(-13.38%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADPT annual depreciation & amortization is $19.26 million, with the most recent change of -$2.98 million (-13.38%) on December 31, 2024.
  • During the last 3 years, ADPT annual D&A has risen by +$5.30 million (+38.01%).
  • ADPT annual D&A is now -13.38% below its all-time high of $22.23 million, reached on December 31, 2023.

Performance

ADPT Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

quarterly D&A:

$4.73M+$283.00K(+6.36%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT quarterly depreciation & amortization is $4.73 million, with the most recent change of +$283.00 thousand (+6.36%) on March 31, 2025.
  • Over the past year, ADPT quarterly D&A has dropped by -$483.00 thousand (-9.26%).
  • ADPT quarterly D&A is now -17.91% below its all-time high of $5.76 million, reached on September 30, 2023.

Performance

ADPT quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

TTM D&A:

$18.77M-$483.00K(-2.51%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT TTM depreciation & amortization is $18.77 million, with the most recent change of -$483.00 thousand (-2.51%) on March 31, 2025.
  • Over the past year, ADPT TTM D&A has dropped by -$3.25 million (-14.75%).
  • ADPT TTM D&A is now -15.55% below its all-time high of $22.23 million, reached on December 31, 2023.

Performance

ADPT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADPTincome statement metrics

ADPT Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.4%-9.3%-14.8%
3 y3 years+38.0%-6.4%+14.9%
5 y5 years+147.2%+139.2%+135.1%

ADPT Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.4%+38.0%-17.9%+6.4%-15.6%+14.9%
5 y5-year-13.4%+147.2%-17.9%+139.2%-15.6%+135.1%
alltimeall time-13.4%+232.2%-17.9%+226.1%-15.6%+1193.8%

ADPT Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.73M(+6.4%)
$18.77M(-2.5%)
Dec 2024
$19.26M(-13.4%)
$4.45M(-3.1%)
$19.26M(-4.7%)
Sep 2024
-
$4.59M(-8.2%)
$20.20M(-5.5%)
Jun 2024
-
$5.00M(-4.0%)
$21.37M(-3.0%)
Mar 2024
-
$5.21M(-3.3%)
$22.02M(-0.9%)
Dec 2023
$22.23M(+6.3%)
$5.39M(-6.4%)
$22.23M(+0.5%)
Sep 2023
-
$5.76M(+1.9%)
$22.13M(+1.7%)
Jun 2023
-
$5.65M(+4.2%)
$21.75M(+2.2%)
Mar 2023
-
$5.42M(+2.6%)
$21.29M(+1.8%)
Dec 2022
$20.92M(+49.9%)
$5.29M(-1.8%)
$20.92M(+2.1%)
Sep 2022
-
$5.38M(+3.6%)
$20.48M(+10.0%)
Jun 2022
-
$5.20M(+2.7%)
$18.63M(+14.0%)
Mar 2022
-
$5.06M(+4.3%)
$16.34M(+17.1%)
Dec 2021
$13.95M
$4.85M(+37.4%)
$13.95M(+21.8%)
Sep 2021
-
$3.53M(+21.4%)
$11.46M(+13.7%)
DateAnnualQuarterlyTTM
Jun 2021
-
$2.90M(+8.8%)
$10.07M(+9.9%)
Mar 2021
-
$2.67M(+13.6%)
$9.16M(+8.2%)
Dec 2020
$8.47M(+8.7%)
$2.35M(+9.7%)
$8.47M(+3.4%)
Sep 2020
-
$2.14M(+7.3%)
$8.20M(+1.0%)
Jun 2020
-
$2.00M(+1.0%)
$8.11M(+1.6%)
Mar 2020
-
$1.98M(-4.7%)
$7.99M(+2.5%)
Dec 2019
$7.79M(+29.8%)
$2.08M(+0.6%)
$7.79M(+6.6%)
Sep 2019
-
$2.06M(+10.3%)
$7.31M(+8.9%)
Jun 2019
-
$1.87M(+4.9%)
$6.71M(+6.0%)
Mar 2019
-
$1.78M(+11.9%)
$6.33M(+5.5%)
Dec 2018
$6.00M(+3.5%)
$1.59M(+8.7%)
$6.00M(+36.1%)
Sep 2018
-
$1.47M(-1.7%)
$4.41M(+49.8%)
Jun 2018
-
$1.49M(+2.8%)
$2.94M(+102.8%)
Mar 2018
-
$1.45M
$1.45M
Dec 2017
$5.80M
-
-

FAQ

  • What is Adaptive Biotechnologies annual depreciation & amortization?
  • What is the all time high annual D&A for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies annual D&A year-on-year change?
  • What is Adaptive Biotechnologies quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies quarterly D&A year-on-year change?
  • What is Adaptive Biotechnologies TTM depreciation & amortization?
  • What is the all time high TTM D&A for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies TTM D&A year-on-year change?

What is Adaptive Biotechnologies annual depreciation & amortization?

The current annual D&A of ADPT is $19.26M

What is the all time high annual D&A for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high annual depreciation & amortization is $22.23M

What is Adaptive Biotechnologies annual D&A year-on-year change?

Over the past year, ADPT annual depreciation & amortization has changed by -$2.98M (-13.38%)

What is Adaptive Biotechnologies quarterly depreciation & amortization?

The current quarterly D&A of ADPT is $4.73M

What is the all time high quarterly D&A for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high quarterly depreciation & amortization is $5.76M

What is Adaptive Biotechnologies quarterly D&A year-on-year change?

Over the past year, ADPT quarterly depreciation & amortization has changed by -$483.00K (-9.26%)

What is Adaptive Biotechnologies TTM depreciation & amortization?

The current TTM D&A of ADPT is $18.77M

What is the all time high TTM D&A for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high TTM depreciation & amortization is $22.23M

What is Adaptive Biotechnologies TTM D&A year-on-year change?

Over the past year, ADPT TTM depreciation & amortization has changed by -$3.25M (-14.75%)
On this page